Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26db05f349a12e10706b1e5ea02c860a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ab2d5a2df259f7d10d8f78fa006c89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14a9ba3779b93fb39e7c0460f702ef5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e54b3819fa25b3d5ab3628e85e3ff42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb4ea45b045b3d397481e23101a6d304 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4ead6158fa635796a5fa4d48ffc357a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eaa04efaa82c8be900a72dcef1e2724b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1df08eecf2c63d15390b681d2a5ca109 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed5535940fecbf5919084dc5d4888d40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56369c2eeb69a0da40c14911f8f74520 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-556 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
filingDate |
2007-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b405cd22769c52e5e68fcadd2de20bd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83a7b6459a497d2f1b3c2fcd4de4131b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58157249acfa4f879284e25257b698f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16a482f6bef72a4c17d8638ce36197de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8eb6cb670eb228eaa9a5520b22df3be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df87bdccf2aec42417ef7d48ec1706e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2706c424abc5713ff86fe0c18c08371 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_640929079f5c72ed0f7fd14acece1a4f |
publicationDate |
2007-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2007113368-A1 |
titleOfInvention |
Use of hexapeptides for preparing angiotensin 1 converting enzyme medicinal products |
abstract |
The invention consists in using synthetic hexapeptides as bioactive products. These are peptides with six amino acid residues as effective inhibitors of angiotensin converting enzyme (ACE). The peptides that are the subject of the patent may be obtained chemically or biotechnologically. Of special interest are those synthesized exclusively from the D-stereoisomers of natural amino acids since this method affords greater stability in addition to their in vitro and/or ex vivo angiotensin converting enzyme inhibitory activity measured as the reduction in the contraction of rabbit carotid arteries induced by exposure to angiotensin 1. These nutraceutical products, possibly in the form of bioactive peptides, are useful both in the food industry and in the pharmaceutical industry. |
priorityDate |
2006-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |